- Home
- EXEL vs GMED Comparison
EXEL vs GMED Comparison
Compare EXEL & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- GMED
- Stock Information
- Founded
- EXEL 1994
- GMED 2003
- Country
- EXEL United States
- GMED United States
- Employees
- EXEL N/A
- GMED N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- GMED Medical/Dental Instruments
- Sector
- EXEL Health Care
- GMED Health Care
- Exchange
- EXEL Nasdaq
- GMED Nasdaq
- Market Cap
- EXEL 9.4B
- GMED 9.6B
- IPO Year
- EXEL 2000
- GMED 2012
- Fundamental
- Price
- EXEL $37.42
- GMED $76.66
- Analyst Decision
- EXEL Buy
- GMED Buy
- Analyst Count
- EXEL 18
- GMED 13
- Target Price
- EXEL $37.59
- GMED $97.09
- AVG Volume (30 Days)
- EXEL 2.8M
- GMED 1.4M
- Earning Date
- EXEL 04-29-2025
- GMED 05-06-2025
- Dividend Yield
- EXEL N/A
- GMED N/A
- EPS Growth
- EXEL 170.77
- GMED N/A
- EPS
- EXEL 1.76
- GMED 0.75
- Revenue
- EXEL $2,168,701,000.00
- GMED $2,519,355,000.00
- Revenue This Year
- EXEL $5.45
- GMED $8.56
- Revenue Next Year
- EXEL $10.32
- GMED $6.73
- P/E Ratio
- EXEL $21.43
- GMED $102.16
- Revenue Growth
- EXEL 18.50
- GMED 60.62
- 52 Week Low
- EXEL $20.14
- GMED $49.33
- 52 Week High
- EXEL $40.02
- GMED $94.93
- Technical
- Relative Strength Index (RSI)
- EXEL 58.85
- GMED 48.37
- Support Level
- EXEL $36.68
- GMED $72.00
- Resistance Level
- EXEL $37.99
- GMED $73.94
- Average True Range (ATR)
- EXEL 1.09
- GMED 2.14
- MACD
- EXEL -0.11
- GMED 0.70
- Stochastic Oscillator
- EXEL 49.87
- GMED 82.24
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.